YOGI LIMITED (YOGI.BO)
INR 57.32
(0.56%)
INR 57.32
(0.56%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -294.64 Million | -312.47 Million | 9.24 Million | 527 Thousand | 748.83 Thousand | -1.44 Million |
| Net Income | -3.81 Million | -3.02 Million | -23 Thousand | 552 Thousand | -1.26 Million | 1.33 Million |
| Depreciation & Amortization | 19 Thousand | 2000.00 | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -285.84 Million | -312.27 Million | 7.97 Million | 99.99 Thousand | 3.32 Million | -1.98 Million |
| Other non-cash items | -5.01 Million | 2.82 Million | 1.29 Million | -124.99 Thousand | -1.31 Million | -790.48 Thousand |
| Investing Cash Flow | -10 Million | -2.2 Million | -1.27 Million | 70 Thousand | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -10 Million | -2.2 Million | -1.27 Million | 70 Thousand | - | - |
| Financing Cash Flow | 307.88 Million | 296.4 Million | - | - | - | 10.02 Million |
| Debt repayment | -83.75 Million | -140.16 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 391.64 Million | 156.24 Million | - | - | - | 10.02 Million |
| Accounts receivables | - | - | 171 Thousand | -165 Thousand | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -213.22 Million | -312.77 Million | 8.25 Million | -766 Thousand | 3.52 Million | -1.88 Million |
| Other working capital | -72.62 Million | 499 Thousand | -457 Thousand | 1.03 Million | -207.23 Thousand | -107.61 Thousand |
| Cash at beginning of period | 443 Thousand | 18.71 Million | 10.74 Million | 10.14 Million | 9.39 Million | 828.08 Thousand |
| Cash at end of period | 3.67 Million | 443 Thousand | 18.71 Million | 10.74 Million | 10.14 Million | 9.39 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 3.23 Million | -18.26 Million | 7.96 Million | 596.24 Thousand | 748.83 Thousand | 8.57 Million |
| Free Cash Flow | -294.64 Million | -312.47 Million | 9.24 Million | 527 Thousand | 748.83 Thousand | -1.44 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.58 Million | 1.38 Million | -3.81 Million | -956 Thousand | -1.55 Million | -2.68 Million |
| Depreciation & Amortization | - | - | 19 Thousand | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -285.84 Million | - | - | - |
| Other non-cash items | 1.58 Million | -1.38 Million | -5.01 Million | 956 Thousand | 1.55 Million | 2.68 Million |
| Investing Cash Flow | - | - | -10 Million | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -10 Million | - | - | - |
| Financing Cash Flow | - | - | 307.88 Million | - | - | - |
| Debt repayment | - | - | -83.75 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 391.64 Million | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -213.22 Million | - | - | - |
| Other working capital | - | - | -72.62 Million | - | - | - |
| Cash at beginning of period | - | - | 443 Thousand | - | - | - |
| Cash at end of period | - | - | 3.67 Million | - | - | - |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 3.23 Million | - | - | - |
| Free Cash Flow | - | - | -294.64 Million | - | - | - |
SGL
3577
0L5V
BORORENEW
BIOTEC
SLM